Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L Bisi
Effect of a Fixed-Dose Combination of Emtricitabine, Tenofovir and Efavirenz on Adherence and Treatment Acceptability (ADONE Study)
Journal of the International AIDS Society
Environmental
Public Health
Infectious Diseases
Occupational Health
Related publications
Chromatographic Separation and in Vitro Dissolution Assessment of Tenofovir Disoproxil Fumarate, Emtricitabine and Nevirapine in a Fixed Dose Combination of Antiretrovirals
Journal of Applied Pharmaceutical Science
Medicine
Toxicology
Pharmaceutics
Pharmacology
Patient-Reported Symptoms on the Antiretroviral Regimen Efavirenz/Emtricitabine/Tenofovir
AIDS Patient Care and STDs
Environmental
Public Health
Infectious Diseases
Occupational Health
Efavirenz, Tenofovir and Emtricitabine Combined With First Line Tuberculosis Treatment in TB–HIV-coinfected Tanzania Patients: A Pharmacokinetic and Safety Study
Antiviral Therapy
Infectious Diseases
Pharmacology
First-Line Antiretroviral Therapy With Efavirenz Plus Tenofovir Disiproxil Fumarate/Emtricitabine or Rilpivirine Plus Tenofovir Disiproxil Fumarate/Emtricitabine: A Durability Comparison
HIV Medicine
Health Policy
Infectious Diseases
Pharmacology
Clinical Study on the Effect of Moringa Oleifera on Serum Level of Glucose and Tryglyceride in Subjects Taken Tenofovir, Lamivudine and Efavirenz Combination Regimen
European Scientific Journal ESJ
Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naive Adults With Hiv-1 Infection in the United Kingdom
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Switch From a ZDV/3TC-based Regimen to a Completely Once Daily (QD) Regimen of Emtricitabine/Tenofovir DF Fixed Dose Combination Plus a Third QD Agent (SONETT)
European Journal of Medical Research
Medicine
Effect of Fixed Dose Combination Treatment on Adherence and Risk Factor Control Among Patients at High Risk of Cardiovascular Disease: Randomised Controlled Trial in Primary Care
British Medical Journal
Medicine
Is Tenofovir/Emtricitabine Teratogenic?
Therapeutic Advances in Drug Safety
Pharmacology
